Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study.

Autor:	Awada, A.1 ahmad.awada@bordet.be, Albanell, J.2, Canney, P. A.3, Dirix, L. Y.4, Gil, T.1, Cardoso, F.1, Gascon, P.2, Piccart, M. J.1, Baselga, J.5
Zdroj:	British Journal of Cancer. 5/5/2008, Vol. 98 Issue 9, p1500-1507. 8p. 5 Charts, 1 Graph.
Databáze:	Academic Search Ultimate
Externí odkaz:	Zobrazit plný text záznamu